文献速递腹部CTMR

定量影像组学与定性LI-RADS影像描述符用于无创评估肝细胞癌β-catenin突变状态

Quantitative radiomics and qualitative LI-RADS imaging descriptors for non-invasive assessment of β-catenin mutation status in hepatocellular carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2024-05-23

该回顾性研究纳入134例病理证实且已知β-catenin活化状态的肝细胞癌患者,基于CT或MR图像提取影像组学特征并评估LI-RADS v2018定性描述符,构建预测模型。影像组学模型AUC为0.70,定性描述符模型AUC为0.64,两者联合后AUC升至0.88;结节内结节征与β-catenin突变显著相关。

要点

  • LI-RADS定性描述符联合CT/MRI影像组学预测HCC β-catenin突变的AUC达0.88。
  • 单独影像组学模型AUC为0.70,单独定性描述符模型AUC为0.64。
  • LI-RADS描述符中结节内结节征与β-catenin突变显著相关(p=0.015)。

核心结论

  • 联合LI-RADS描述符与CT/MRI影像组学可高置信度判断HCC β-catenin活化状态,使精准医学成为可能。

研究设计与样本

  • IRB批准的回顾性研究,纳入134例病理证实的HCC且具备β-catenin活化状态、组织学评估前1年内行肝脏CT或MR检查的受试者。

关键影像表现/征象

  • LI-RADS描述符中结节内结节征与β-catenin突变显著相关(p=0.015)。
  • 88个影像组学特征与β-catenin突变显著相关(p<0.05)。

诊断标准与关键数值

  • 影像组学特征模型预测β-catenin突变的AUC为0.70(95%CI 0.60, 0.79)。
  • LI-RADS定性描述符模型预测β-catenin突变的AUC为0.64(95%CI 0.52, 0.74;p=0.468)。
  • 影像组学与定性描述符联合模型预测β-catenin突变的AUC为0.88(95%CI 0.80, 0.92;p=0.009)。

临床应用与阅片要点

  • 阅片时可关注LI-RADS v2018中的结节内结节征,该征象与β-catenin突变显著相关(p=0.015)。
  • 对病理证实HCC且已知β-catenin状态者,可基于CT或MR图像行3D分割提取影像组学特征构建预测模型。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Gain-of-function mutations in CTNNB1, gene encoding for β-catenin, are observed in 25-30% of hepatocellular carcinomas (HCCs). Recent studies have shown β-catenin activation to have distinct roles in HCC susceptibility to mTOR inhibitors and resistance to immunotherapy. Our goal was to develop and test a computational imaging-based model to non-invasively assess β-catenin activation in HCC, since liver biopsies are often not done due to risk of complications.

METHODS: This IRB-approved retrospective study included 134 subjects with pathologically proven HCC and available β-catenin activation status, who also had either CT or MR imaging of the liver performed within 1 year of histological assessment. For qualitative descriptors, experienced radiologists assessed the presence of imaging features listed in LI-RADS v2018. For quantitative analysis, a single biopsy proven tumor underwent a 3D segmentation and radiomics features were extracted. We developed prediction models to assess the β-catenin activation in HCC using both qualitative and quantitative descriptors.

RESULTS: There were 41 cases (31%) with β-catenin mutation and 93 cases (69%) without. The model's AUC was 0.70 (95% CI 0.60, 0.79) using radiomics features and 0.64 (0.52, 0.74; p = 0.468) using qualitative descriptors. However, when combined, the AUC increased to 0.88 (0.80, 0.92; p = 0.009). Among the LI-RADS descriptors, the presence of a nodule-in-nodule showed a significant association with β-catenin mutations (p = 0.015). Additionally, 88 radiomics features exhibited a significant association (p < 0.05) with β-catenin mutations.

CONCLUSION: Combination of LI-RADS descriptors and CT/MRI-derived radiomics determine β-catenin activation status in HCC with high confidence, making precision medicine a possibility.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Arefan D, D'Ardenne NM, Iranpour N, et al. Quantitative radiomics and qualitative LI-RADS imaging descriptors for non-invasive assessment of β-catenin mutation status in hepatocellular carcinoma. Abdom Radiol (NY). 2024. PMID: 38782785. doi:10.1007/s00261-024-04344-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。